← Back to Search

Support Group for Bronchiectasis (BronchConnect Trial)

N/A
Waitlist Available
Led By Shoshana Zha, MD/PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3-months, 6-months, 12-months
Awards & highlights

BronchConnect Trial Summary

This trial will assess if support groups improve quality of life for those with NCFBE, a chronic lung disease with no targeted therapy. It will measure quality of life, anxiety, and exacerbation rates.

Who is the study for?
This trial is for adults with non-cystic fibrosis bronchiectasis confirmed by a CT chest scan, where it's the main lung issue. Participants must be able to give informed consent and speak English well enough to have full conversations.Check my eligibility
What is being tested?
The study examines how joining a virtual support group affects life quality and anxiety in people with NCFBE. It measures changes through questionnaires and checks if their condition gets worse less often.See study design
What are the potential side effects?
Since this trial involves participation in a support group rather than medication, there are no direct medical side effects. However, discussing health issues could potentially cause emotional discomfort.

BronchConnect Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3-months, 6-months, 12-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3-months, 6-months, 12-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anxiety
Health-related quality of life
Secondary outcome measures
Exacerbation Rate
Participation
Rate of post-group survey

BronchConnect Trial Design

1Treatment groups
Experimental Treatment
Group I: Support GroupExperimental Treatment1 Intervention
Non-randomized pre-post trial, in which each participant will serve as their own control. Participants will be recruited from a bronchiectasis specialty clinic.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Support Group
2016
N/A
~640

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,515 Total Patients Enrolled
Shoshana Zha, MD/PhDPrincipal InvestigatorUniversity of California, San Francisco

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this project still open?

"According to the information displayed on clinicaltrials.gov, this medical research is no longer enrolling participants as of December 1st 2023. Despite this trial's inactive status, there are currently 428 other similar trials that remain open for recruitment."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Impact of Support Groups for Patients With Non-Cystic Fibrosis Bronchiectasis
2024. "Impact of Support Groups for Patients With Non-Cystic Fibrosis Bronchiectasis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06164470.
All > Bronchiectasis > Cystic Fibrosis
~27 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top